CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
Abnova (Taiwan) Corporation Company Snapshot
Abnova (Taiwan) Corporation operates within the Biological products exc. diagnostic sector. In addition to historical fundamental analyses, the complete report available to purchase compares Abnova (Taiwan) with three other companies in this sector in Taiwan: EirGenix Inc (2016 sales of 253.11 million Taiwanese Dollars [US$8.39 million] ), Adimmune Corporation (606.73 million Taiwanese Dollars [US$20.11 million] of which 100% was Medicines), and Genmont Biotech Inc (540.78 million Taiwanese Dollars [US$17.93 million] of which 64% was Jingyue Company).

Sales Analysis. During the year ended December of 2016, sales at Abnova (Taiwan) were 439.83 million Taiwanese Dollars (US$14.58 million). This is a decrease of 2.6% versus 2015, when the company's sales were 451.37 million Taiwanese Dollars. The sales level in 2016 was fairly close to the level five years ago: in 2011, Abnova (Taiwan) had sales of 472.57 million Taiwanese Dollars.
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
Abnova (Taiwan) Corporation
  Stock Performance Chart for Abnova (Taiwan) Corporation
 
  Stock Data: Recent Stock Performance:
  Current Price (9/22/2017): 39.30
(Figures in Taiwanese Dollars)
1 Week -5.2%   13 Weeks 13.2%  
4 Weeks 16.5%   52 Weeks 13.4%  
 
Abnova (Taiwan) Corporation Key Data:
  Ticker: 4133 Country: Taiwan
  Exchanges: TAI Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Biological Products Exc. Diagnostic
  2016 Sales 439,826,000
(Year Ending Jan 2017).
Employees: 190
  Currency: Taiwanese Dollars Market Cap: 2,379,756,362
  Fiscal Yr Ends: December Shares Outstanding: 60,553,597
  Share Type: Gu Closely Held Shares: 21,247,705
 
 
Sponsored Links
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.